REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Share News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Rosslyn promotes new CEO; Celtic CEO ready to start

Tue, 06th Apr 2021 14:54

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

GlaxoSmithKline PLC - Brentford, Middlesex-based pharmaceutical firm - Hires Anne Beal as non-executive director, starting May 6. Beal will replace Lynn Elsenhans as chair of the Corporate Responsibility Committee, and Elsenhans will stay on the board for an additional year to allow for a handover. Beal is founder and chief executive officer of AbsoluteJOI Skincare. She spent six years at Harvard Medical School and Massachusetts General Hospital, instructing in paediatrics.

----------

Assura PLC - Warrington, England-based primary care property investor - Jenefer Greenwood will retire as non-executive director at Assura's July 6 annual general meeting. Hires Emma Cariaga, Noel Gordon and Sam Barrell as new non-executive directors, starting on May 1. Cariaga is joint head of Canada Water Development on the executive committee of British Land Co PLC. Gordon was global managing director at consultants Accenture. For the UK National Health Service, he was chair of NHS Digital and a non-executive director of NHS England. Barrell is chief operating officer of the Crick Institute, which supports biomedical research.

----------

Rosslyn Data Technologies PLC - London-based cloud enterprise data analytics platform - Chief Executive Officer Roger Bullen steps down from board, effective immediately, but will remain as an adviser for six months. Bullen served for five years as CEO and chief financial officer. Chief Customer Officer Paul Watts is promoted to CEO. Watts joined Rosslyn back in August and before that was CEO of Blue Prism KK Japan, a robotic process automation company. Both Chair James Appleby and CFO Ash Mehta will take on additional responsibilities. Rosslyn also says it expects its results for the financial year ending April 30 to be in line with market expectations. It will issue a trading update in late May.

----------

Celtic PLC - Glasgow football club - Confirms that Dominic McKay will join Celtic on April 19 before replacing retiring Peter Lawwell as chief executive on July 1. Scottish Rugby confirmed that McKay will leave as chief operating officer on April 16, following a successful handover. McKay, who also was chair of the Guinness Pro14 annual rugby union competition, will join the Celtic board.

----------

Amryt Pharma PLC - London-based biopharmaceutical firm focused on rare and orphan diseases - Hires Sheila Frame as president for the Americas. Frame has held senior positions at Novartis AG, Bristol-Myers Squibb Co and AstraZeneca PLC.

----------

MyHealthChecked PLC - Cardiff-based consumer home-testing healthcare - Peter Dines steps down as non-executive director on Tuesday. Dines is chief operating officer of Mercia Asset Management PLC, whose funds have a 28% stake in MyHealthChecked. He is standing down to focus on other portfolio companies.

----------

Northamber PLC - Chessington, Surrey-based audio-visual and information technology distributor - Promotes Finance Director Tony Lee to board and hires Riccardo Reggio as a non-executive director, both from last Thursday. Lee re-joined Northamber in August of last year, having previously been finance director from 2003 to 2005. Reggio is a corporate strategy and acquisitions adviser who worked at Monitor Group for 15 years.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
9 Dec 2020 09:47

Amryt Pharma gets approval for 'Lojuxta' in Brazil

(Sharecast News) - Biopharmaceutical company Amryt Pharma announced on Wednesday that it has received marketing authorisation approval from the Brazilian Health Regulatory Agency (ANVISA) for 'Lojuxta', or lomitapide.

Read more
8 Dec 2020 09:22

Amryt Pharma raising $40m for working capital, acquisitions

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma has entered into agreements to raise $40m, it announced on Tuesday, to fund working capital as well as potential acquisitions and licence deals.

Read more
29 Oct 2020 19:11

IN BRIEF: Amryt Pharma Posts Success From Filsuvez Trial

IN BRIEF: Amryt Pharma Posts Success From Filsuvez Trial

Read more
29 Oct 2020 16:09

Amryt shares rise on success of 'EASE' trial

(Sharecast News) - Biopharmaceutical company Amryt Pharma announced positive results from its pivotal phase 23 'EASE' trial of 'Filsuvez', or 'Oleogel-S10', previously 'AP101', on Thursday.

Read more
29 Oct 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
19 Oct 2020 15:43

IN BRIEF: Amryt Pharma Signs Distribution Deal With Swixx Biopharma

IN BRIEF: Amryt Pharma Signs Distribution Deal With Swixx Biopharma

Read more
19 Oct 2020 08:34

Amryt Pharma signs new distribution deal with Swixx BioPharma

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced the signing of a distribution agreement with Swixx BioPharma of Baar, Switzerland on Monday.

Read more
15 Sep 2020 22:08

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

Read more
9 Sep 2020 13:26

Amryt shares surge on Filsuvez phase 3 results

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced positive top-line results from its pivotal phase 3 'EASE' trial of 'Filsuvez' for the treatment of dystrophic and junctional epidermolysis bullosa on Wednesday.

Read more
9 Sep 2020 10:50

UK WINNERS & LOSERS SUMMARY: Amryt Surges Nearly 50% On Trial Results

UK WINNERS & LOSERS SUMMARY: Amryt Surges Nearly 50% On Trial Results

Read more
9 Sep 2020 10:31

Amryt Pharma Shares Jump On Positive Third-Phase Filsuvez Trial Result

Amryt Pharma Shares Jump On Positive Third-Phase Filsuvez Trial Result

Read more
8 Jul 2020 17:13

IN BRIEF: Amryt Lauds Nasdaq Global Listing "Milestone"

IN BRIEF: Amryt Lauds Nasdaq Global Listing "Milestone"

Read more
24 Jun 2020 14:12

IN BRIEF: Amryt Pharma To List American Depository Shares In US

IN BRIEF: Amryt Pharma To List American Depository Shares In US

Read more
4 Jun 2020 14:58

UK DIRECTOR DEALINGS SUMMARY: XP Power Chair In GBP3.6 Million Sale

UK DIRECTOR DEALINGS SUMMARY: XP Power Chair In GBP3.6 Million Sale

Read more
3 Jun 2020 16:23

UK DIRECTOR DEALINGS SUMMARY: Braveheart Investment CEO Cuts Stake

UK DIRECTOR DEALINGS SUMMARY: Braveheart Investment CEO Cuts Stake

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.